- Waldencast Reports Q1 2024 Financial Results
- Waldencast plc Announces First Quarter Fiscal 2024 Earnings Release Date, Conference Call and Webcast
- Waldencast Announces Participation in CreatorIQ Connect Europe
- Waldencast Reports Fiscal Year 2023 Financial Results
- Waldencast Regains Compliance with Nasdaq Filing Requirements
- Waldencast Reports First Half 2023 Results
- Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream
- Waldencast Receives Positive Nasdaq Listing Determination
- Waldencast Announces New “Creative Council” of Industry Pioneers and Disruptors
- Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.
More ▼
Key statistics
On Wednesday, Waldencast PLC (WALD:NAQ) closed at 4.35, 3.82% above its 52-week low of 4.19, set on May 17, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.70 |
---|---|
High | 4.79 |
Low | 4.30 |
Bid | 1.74 |
Offer | 5.69 |
Previous close | 4.35 |
Average volume | 119.37k |
---|---|
Shares outstanding | 122.19m |
Free float | 52.90m |
P/E (TTM) | -- |
Market cap | 531.52m USD |
EPS (TTM) | -0.9871 USD |
Data delayed at least 15 minutes, as of May 22 2024 21:00 BST.
More ▼